Valneva SE (VALN) Invested Capital (2019 - 2026)
Valneva SE (VALN) posted quarterly Invested Capital of $20.8 million for Q1 2026, down 7.28% year-on-year from $22.4 million in Q1 2025, and down 89.8% on a QoQ basis from $203.9 million in Q4 2025.
Valneva SE (VALN) Invested Capital (2019 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Invested Capital for 8 consecutive years, with $20.8 million the latest figure, recorded in Q1 2026.
- Quarterly Invested Capital fell 7.28% year-over-year to $20.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $483.3 million (up 4.36% YoY) and the FY2025 annual result came in at $203.9 million, down 4.36% from the prior year.
- Invested Capital eased to $20.8 million in Q1 2026 per VALN's latest filing, from $203.9 million in the prior quarter.
- Over the last five years, Invested Capital for VALN reached as high as $213.2 million in Q4 2024 and fell as low as $13.3 million in Q1 2022.
- A 5-year average of $88.1 million and a median of $38.5 million in 2023 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital sank 81.0% — and 2024, when it jumped 751.21%.
- Year by year, Invested Capital stood at $101.5 million in 2022, then jumped by 87.84% to $190.6 million in 2023, then climbed by 11.85% to $213.2 million in 2024, then decreased by 4.36% to $203.9 million in 2025, then slumped by 89.8% to $20.8 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $20.8 million, $203.9 million, and $66.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 20.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.79 Mn |
| Dec 31, 2025 | 203.92 Mn |
| Sep 30, 2025 | 66.95 Mn |
| Jun 30, 2025 | 191.63 Mn |
| Mar 31, 2025 | 22.42 Mn |
| Dec 31, 2024 | 213.22 Mn |
| Sep 30, 2024 | 22.14 Mn |
| Jun 30, 2024 | 205.30 Mn |
| Mar 31, 2024 | 25.50 Mn |
| Dec 31, 2023 | 190.63 Mn |
| Sep 30, 2023 | 38.48 Mn |
| Jun 30, 2023 | 24.12 Mn |
| Mar 31, 2023 | 16.11 Mn |
| Dec 31, 2022 | 101.49 Mn |
| Sep 30, 2022 | 14.22 Mn |
| Jun 30, 2022 | 126.93 Mn |
| Mar 31, 2022 | 13.35 Mn |
| Dec 31, 2021 | 65.81 Mn |
| Dec 31, 2020 | 52.56 Mn |
| Dec 31, 2019 | 29.95 Mn |